Associate at Osler, a legal firm that helps clients recognize, develop and realize innovative venture capital opportunities. Osler acts for more than 1,500 early, growth and late-stage ventures and venture investors across Canada, the United States and around the world.

Community and Impact Manager at The Forum, a Canadian-based charity that helps self-identified women entrepreneurs access the resources and community they need to thrive in business.

General Partner at Audaxa Ventures based in Canada, accepting global accredited investors. Audaxa Ventures is committed to making a positive impact and believe they can address the most pressing climate and health challenges by investing in diverse women + non-binary founders. They prioritize investments that not only improve the world and their communities but also provide their portfolio companies with the market access needed to expand their ventures and foster growth.

With 38 years of experience, Gordon's primary focus has been developing quality management systems in start-up or early-stage organizations. Gordon possesses extensive knowledge of Canadian Medical Device Regulations, FDA QSR, EU Medical device directive, the upcoming EU MDR, and other international regulatory agencies.

Principal at Whitecap Venture Partners, a VC fund focused on B2B software and Med Tech, honing in on verticals where we can make it our mission to help founders make a profound difference.

Senior Advisor, Health Venture Services at MaRS Discovery District, one of the world’s largest urban innovation hubs. MaRS supports promising high-growth companies to scale their businesses globally, while tackling key societal challenges in areas such as Health, Cleantech, Finance, Transportation, AI, and others. In addition to helping start-ups launch, grow and scale, the MaRS community is dedicated to cross-disciplinary collaboration, commercialization of discoveries, and driving ideas to impact.

Partner at Esplanade HealthTech Ventures, Canada’s leading digital healthcare venture capital firm, investing in the US, Canada, Europe and Israel. Esplanade focuses on early-stage and high-growth companies shaping the future of healthcare delivery and actively empowering them to scale and grow.Esplanade has a strong focus on investment in women's health including several investments in the menopause and osteoporosis space.

EIR at MaRS Discovery District, one of the world’s largest urban innovation hubs. MaRS supports promising high-growth companies to scale their businesses globally, while tackling key societal challenges in areas such as Health, Cleantech, Finance, Transportation, AI, and others. In addition to helping start-ups launch, grow and scale, the MaRS community is dedicated to cross-disciplinary collaboration, commercialization of discoveries, and driving ideas to impact.

Venture Manager at Next AI, a world-class founder and venture development acceleration network for AI-enabled startups. Leveraging a renowned ecosystem of AI and business experts, Next AI provides support on both AI product development and market commercialization. Each year, Next AI identifies the top early-stage teams developing ambitious AI-powered solutions and provides them with the mentorship, education and network to have a global impact.

Principal at IngVentions, a firm provides timely consultation in the areas of product development, regulatory affairs, M&A strategy and due diligence. Ing is also an expert advisor in Life Sciences for Innovation Factory Hamilton and a business mentor at The Forge, McMaster University.

Co-founder and Principal at Cross-Border Impact Ventures, an impact venture capital firm on a mission to revolutionize venture capital investing in health technology. They invest in world-class companies that create better health technologies benefiting women, children and adolescents inclusively and globally.

Senior Manager, Health Sciences at MaRS,  one of the largest urban innovation hubs. They support companies to scale their businesses globally, while tackling key societal challenges in areas such as Health, Cleantech, Finance, Transportaion, Ai and others. The MaRS community is dedicated to cross-disciplinary collaboration, commercialization of discoveries and  driving ideas to impact."

Founder & Principal at Venture Catalyst, LLC, an investment consulting firm specialized in discovering and elevating early-stage ventures. They support investors' efforts to source, vet, and assess the potential of interesting, early-stage investment prospects within their competitive landscape.

Associate at iGan Partners, one of the leading healthcare VC funds in Canada, investing globally in Seed to Series A med tech and healthcare software companies. We partner with exceptional founders to commercialize and scale medical innovations.

Managing Partner at Amplify Capital, the evolution of the MaRS Catalyst Fund, investing in mission-driven, double-bottom-line disruptors in health, education and cleantech.

Associate at Wittington Ventures, a multi-stage focus fund affiliated with iconic businesses in the retail, healthcare, real estate, and financial services verticals.

Investment Manager at CVX Ventures, the Nordic's most value-adding venture investor. CVX invests in carefully chosen pre-seed and seed-stage tech venture and growth opportunities through its network-based model. Sara led the investment in Samphire Neuroscience, a neurotechnology company dedicated to maximising the well-being of women and bridge the gap left by conventional treatments using neuroscience and the lived experience of women. 

Founder & CEO of Cosm Medical, a company on a mission to transform the fast-growing and under-recognized field of female pelvic health through personalized gynecological devices for unique bodies and needs.

CEO and co-founder of Juniper Genomics, a company bringing modern genomics and data science to those trying to conceive to help overcome the barriers and challenges facing IVF patients today.

Analyst at Inovia, a venture capital firm that partners with founders to build impactful and enduring global companies. The team leverages an operator-led mindset to provide founders with multi-stage support, mentorship, and access to a worldwide network. Inovia manages over US$2.2B with operations in Montreal, Toronto, Calgary, Bay Area, and London.

Co-Founder of The Firehood, a movement focused on increasing the participation, leadership and prosperity of women in technology, and GP of Phoenix Fire, an angel fund investing in women entrepreneurs across Canada.

CEO & Founder of Hyivy, a partner for pelvic health journeys that offers holistic, patient-created, pelvic health rehabilitation for patients and clinicians.

Associate at Panache Ventures, Canada's most active pre-seed and seed stage venture capital firm, currently investing out of our new $100M fund. Panache invests in Canada's most ambitious founders across all sectors.

Partner at StandUp Ventures, a $55M seed-stage venture capital fund focused on investing in high-growth ventures with at least one female founder in a key leadership role.